Aberdeen Group plc Cuts Position in Intuitive Surgical, Inc. $ISRG

Aberdeen Group plc lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 380,508 shares of the medical equipment provider’s stock after selling 7,568 shares during the quarter. Aberdeen Group plc owned about 0.11% of Intuitive Surgical worth $215,505,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Holos Integrated Wealth LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $25,000. Kilter Group LLC acquired a new position in shares of Intuitive Surgical during the 2nd quarter valued at $27,000. Greykasell Wealth Strategies Inc. purchased a new stake in Intuitive Surgical during the 3rd quarter worth $27,000. Olistico Wealth LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth $28,000. Finally, Caitlin John LLC acquired a new stake in Intuitive Surgical in the 3rd quarter valued at $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other news, SVP Mark Brosius sold 2,362 shares of the business’s stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16. Following the completion of the sale, the senior vice president owned 3,554 shares of the company’s stock, valued at approximately $1,772,308.72. The trade was a 39.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gary S. Guthart sold 24,500 shares of the company’s stock in a transaction dated Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the completion of the sale, the director owned 3,694 shares in the company, valued at approximately $1,958,189.40. This trade represents a 86.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 32,943 shares of company stock worth $17,279,568 over the last 90 days. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Down 2.7%

Shares of NASDAQ ISRG opened at $452.07 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The business has a 50 day moving average price of $488.87 and a two-hundred day moving average price of $512.97. The firm has a market cap of $160.54 billion, a PE ratio of 57.30, a price-to-earnings-growth ratio of 3.58 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.Intuitive Surgical’s quarterly revenue was up 18.8% on a year-over-year basis. During the same period in the prior year, the company posted $2.21 EPS. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Robert W. Baird decreased their target price on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research report on Friday, January 23rd. BTIG Research reiterated a “buy” rating and set a $616.00 target price on shares of Intuitive Surgical in a report on Friday, January 23rd. Piper Sandler restated an “overweight” rating and issued a $620.00 price target (up from $610.00) on shares of Intuitive Surgical in a report on Friday, January 23rd. UBS Group lowered their price objective on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research report on Tuesday, March 17th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $614.95.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Motley Fool notes Intuitive “maintains edge” despite a March phishing breach — the report argues the incident exposed limited customer/contact data and does not materially impair the company’s core robotic-surgery platform or long-term growth thesis. Read More.
• Neutral Sentiment: The Zacks Analyst Blog flags mixed momentum for Intuitive alongside other large-cap names — the write-up highlights sector dynamics and does not change Intuitive’s longer-term narrative, but it signals cautious analyst tone. Read More.
• Neutral Sentiment: Kalkine Media reports a rating shift that put ISRG in focus on Nasdaq — the note drew trader attention but did not present new fundamental data; it likely amplified volatility as market participants reacted. Read More.
• Negative Sentiment: Coverage (Yahoo/Zacks) highlights growing pricing pressure in China as local rivals expand — analysts flag margin and unit-growth risk if Intuitive must defend share via pricing or increased commercial spend, even as the company leans on local manufacturing and its ecosystem to compete. Read More.
• Negative Sentiment: Zacks downgraded ISRG from “strong-buy” to “hold,” a direct analyst action that can prompt short-term selling and wider re-rating among momentum-driven investors. Read More.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.